Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

National Center for Tumor Diseases (NCT)

The National Center for Tumor Diseases (NCT) is a long-term cooperation between the German Cancer Research Center (DKFZ), excellent partners in university medicine and other outstanding research partners at various locations in Germany.

The Federal Ministry of Education and Research (BMBF) confirmed the NCT expansion with four new sites on February 2, 2023. These are Berlin, SüdWest (Tübingen/Stuttgart-Ulm), WERA (Würzburg with partners Erlangen, Regensburg and Augsburg) and West (Cologne/Essen). With the existing sites in Heidelberg and Dresden, a total of six NCT sites are now cooperating with the DKFZ with the aim of sustainably advancing state-of-the-art clinical cancer research in Germany and thereby improving the treatment outcomes and quality of life of cancer patients.

Expansion of the NCT strengthens clinical cancer research

The expanded NCT specifically addresses the major current weaknesses of clinical cancer research in the German research landscape. With its focus on innovative clinical trials, the NCT enables new developments from the laboratory to be tested clinically quickly and to the highest standards, thereby making better diagnostic and treatment options available to patients. Special emphasis will be placed on personalized oncology, patient participation as research partners, rapid and fair patient access to advances in cancer research, and the training of future generations of clinical cancer researchers.

In its final stage, the expanded NCT will be financed with a total of about 100 million euros per year by the BMBF and the respective host state in a ratio of 90:10. In addition, the funding from the host countries will enable the construction of a patient-oriented NCT building at each of the four new sites.

More information: NCT website

to top
powered by webEdition CMS